营销授权
OCT是您值得信赖的东欧临床试验的营销授权合作伙伴。
We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT是您值得信赖的东欧临床试验的营销授权合作伙伴。
我们的团队为国内外申办者在俄罗斯的营销授权提供全方位优质服务。
虽然，我们轻易即可利用所有临床试验的国际标准和指南，来决定方案的可行性。但作为专家，我们的价值在于适应现有情况，最大限度地实现客户的目标和质量期望。
Natalya Eliseeva
Regulatory Manager
我们的支持服务包括：
• 准备文件档案：行政文件、药物特性说明、技术数据，以及关于药物临床前和临床研究的信息
• 向俄罗斯联邦卫生部提交档案
• 与监管机构有效沟通，处理官方问询和信函
• 获取营销授权证书
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.